US Archives - Page 97 of 119 - European Medical Journal

Tusi: Mysterious New Drug Trend Rising

Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.

E. coli Outbreak in 6 States: CDC Latest

The CDC has issued a health alert linking a multistate Escherichia coli (E. coli) outbreak to McDonald’s Quarter Pounders; the outbreak has spanned six states, with one death and numerous hospitalizations reported.

Study Shows Ozempic Reduced Opioid Overdose By 40%

Prescribed drugs for diabetes may also reduce the risk of opioid overdoses and alcohol intoxication in patients struggling with addiction according to the results of a new study.

CDC Warns of Oropouche Virus Sexual Transmission Risk

Ninety cases of imported Oropouche virus have been reported across five states, primarily in Florida, according to the U.S. Centers for Disease Control and Prevention (CDC).

Avian Flu and Mpox: Emerging Pandemic Risks

The Global Preparedness Monitoring Board (GPMB) has released its latest annual report, spotlighting avian flu and mpox as significant emerging threats with pandemic potential.

Lupus in Pregnancy Linked to Placental Damage

Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.

CDC Warns of Rising Pneumonia and RSV in Children

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

Ketamine Treatment for Bipolar Shows Full Remission

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

Can Diet Quality Slow Prostate Cancer?

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.

Advanced Lung Cancer Wearable Receives FDA Approval

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.